General Information of the Compound
| Compound ID |
CP0866992
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(2,6-difluorophenyl)-3-(3-(2-((2-(ethyloxy)-4-(4-(1-methylethyl)-1-piperazinyl)phenyl)amino)-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C39H38F2N8O2
|
||||||||||||||||||
| Molecular Weight |
688.783
|
||||||||||||||||||
| Canonical SMILES |
CCOc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C39H38F2N8O2/c1-4-51-33-24-28(48-21-19-47(20-22-48)25(2)3)14-15-31(33)43-39-42-17-16-32(44-39)37-35(45-34-13-5-6-18-49(34)37)26-9-7-10-27(23-26)38(50)46-36-29(40)11-8-12-30(36)41/h5-18,23-25H,4,19-22H2,1-3H3,(H,46,50)(H,42,43,44)
Show/Hide
|
||||||||||||||||||
| InChIKey |
KTINPNCRSQJINT-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01101, Insulin receptor
Protein ID: PT01104, Insulin-like growth factor 1 receptor